Literature DB >> 23771271

Interventional trials with anticoagulants in acutely ill medical patients: a methodological pitfall?

Francesco Violi1, Ludovica Perri, Lorenzo Loffredo.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23771271     DOI： 10.1007/s11739-013-0970-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  19 in total

1.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Susan R Kahn; Wendy Lim; Andrew S Dunn; Mary Cushman; Francesco Dentali; Elie A Akl; Deborah J Cook; Alex A Balekian; Russell C Klein; Hoang Le; Sam Schulman; M Hassan Murad
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.

Authors:  Alexander T Cohen; Bruce L Davidson; Alexander S Gallus; Michael R Lassen; Martin H Prins; Witold Tomkowski; Alexander G G Turpie; Jan F M Egberts; Anthonie W A Lensing
Journal:  BMJ       Date:  2006-01-26

3.  Low-molecular-weight heparin and mortality in acutely ill medical patients.

Authors:  Ajay K Kakkar; Claudio Cimminiello; Samuel Z Goldhaber; Rajiv Parakh; Chen Wang; Jean-François Bergmann
Journal:  N Engl J Med       Date:  2011-12-29       Impact factor: 91.245

4.  Prophylaxis of venous thromboembolism in elderly patients with multimorbidity.

Authors:  Maura Marcucci; Alfonso Iorio; Alessandro Nobili; Mauro Tettamanti; Luca Pasina; Codjo Djignefa Djade; Alessandra Marengoni; Francesco Salerno; Salvatore Corrao; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2013-05-08       Impact factor: 3.397

5.  Improving the sensitivity of the Barthel Index for stroke rehabilitation.

Authors:  S Shah; F Vanclay; B Cooper
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

6.  A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score.

Authors:  S Barbar; F Noventa; V Rossetto; A Ferrari; B Brandolin; M Perlati; E De Bon; D Tormene; A Pagnan; P Prandoni
Journal:  J Thromb Haemost       Date:  2010-11       Impact factor: 5.824

7.  A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.

Authors:  M M Samama; A T Cohen; J Y Darmon; L Desjardins; A Eldor; C Janbon; A Leizorovicz; H Nguyen; C G Olsson; A G Turpie; N Weisslinger
Journal:  N Engl J Med       Date:  1999-09-09       Impact factor: 91.245

Review 8.  Do medical patients need to receive pharmacologic prophylaxis for the prevention of venous thromboembolism?

Authors:  Walter Ageno
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

9.  Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy.

Authors:  P D Stein; J W Henry
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

10.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410
View more
  4 in total

1.  Prophylaxis of venous thromboembolism in elderly patients with multi-morbidity: the REPOSI data.

Authors:  Giovanni Di Minno
Journal:  Intern Emerg Med       Date:  2014-10-11       Impact factor: 3.397

2.  Prophylaxis of venous thromboembolism in Internal Medicine Units: the RAMs issue.

Authors:  Antonella Tufano; Giovanni Di Minno
Journal:  Intern Emerg Med       Date:  2018-03-14       Impact factor: 3.397

3.  Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).

Authors:  Luca Depietri; Marco Marietta; Stefania Scarlini; Matteo Marcacci; Elena Corradini; Antonello Pietrangelo; Paolo Ventura
Journal:  Intern Emerg Med       Date:  2018-03-03       Impact factor: 3.397

4.  New oral anticoagulants for the treatment of acute venous thromboembolism: are they safer than vitamin K antagonists? A meta-analysis of the interventional trials.

Authors:  Lorenzo Loffredo; Ludovica Perri; Maria Del Ben; Francesco Angelico; Francesco Violi
Journal:  Intern Emerg Med       Date:  2014-12-25       Impact factor: 3.397
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.